SCHEMBL4806850

SCHEMBL4806850

CC(C)(C)OC(=O)c1ccccc1OCC1CO1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.54
▸ GLA P06280 1/20 0.54
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43
▸ TSHR P16473 4/20 0.41
▸ TP53 P04637 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HIF1A Q16665 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ VDR P11473 1/20 0.41
▸ CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4221154 1.00 ALDH1A1 (0.54) ALDH1A1GLAMEN1KMT2ANPC1
SCHEMBL6216333 0.85 ALDH1A1 (0.58) ALDH1A1GLAMEN1KMT2ALMNA
SCHEMBL4211931 0.85 ALDH1A1 (0.58) ALDH1A1GLAMEN1KMT2ALMNA
SCHEMBL10936580 0.83 ALDH1A1 (0.55) ALDH1A1GLANPC1USP2LMNA
SCHEMBL10602219 0.82 ALDH1A1 (0.59) ALDH1A1GLANPC1LMNARAB9A
SCHEMBL1410038 0.82 ALDH1A1 (0.55) ALDH1A1GLAMEN1KMT2ANPC1
SCHEMBL8069122 0.82 ALDH1A1 (0.54) ALDH1A1GLAKMT2ANPC1USP2
SCHEMBL7281360 0.81 ALDH1A1 (0.61) ALDH1A1GLANPC1USP2LMNA
SCHEMBL10626963 0.80 ALDH1A1 (0.58) ALDH1A1GLAKMT2ANPC1USP2
SCHEMBL8123249 0.79 ALDH1A1 (0.58) ALDH1A1GLAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388020-B2 Benzimidazol derivatives modulate chemokine receptors ASTRAZENECA AB (SE) 2008-06-17 — — US disclosed
US-20040116435-A1 Benzimidazol derivatives modulate chemokine receptors ASTRAZENECA AB (SE) 2004-06-17 — — US disclosed
EP-1373248-A1 BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS AstraZeneca AB (SE) 2004-01-02 — — EP disclosed
WO-2002074763-A9 BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS ASTRAZENECA AB (SE) 2002-10-24 — — WO disclosed
WO-2002074763-A1 BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS ASTRAZENECA AB (SE) 2002-09-26 — — WO disclosed
Send feedback